This valuable work used molecular biology, cell biology, and genetic approaches to unravel individual genes and potential pathways that contribute to paternal mitochondrial inheritance using C.

“We are excited to complete this submission for an ILAP Passport as this Program will help accelerate the clinical development of Lucid-21-302 as a new treatment for Multiple Sclerosis.

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom ...

Sac State just upset multiple SEC programs for a top 100 recruit.

Goliath Resources Significantly Upsizes Fully Funded 2025 Drill Program From 40,000 Up To 60,000 Meters Based On Newly Identified Widespread Abundant Visible Gold In Multiple Drill Holes At The ...